Oliver Luxxe Assets’s Charles River Laboratories CRL Stock Holding History

Oliver Luxxe Assets’s Portfolio CRL Stock Details CRL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.05M	Buy
2021 Q1	–	Sell
2020 Q4	$1.47M	Buy
2020 Q3	$343K	Sell
2020 Q2	$266K	Hold
2020 Q1	$216K	Buy